


1/2

品牌: BD Pharmingen








反应种属:
Human (QC Testing)
Human (QC Testing)
实验应用:
Flow cytometry (Tested During Development)
Flow cytometry (Tested During Development)
产品介绍
产品信息
抗原名称
Lineage

简单描述
Human multipotent mesenchymal stromal cells (MSCs), also referred to as mesenchymal stem cells, are a rare population of adult stem cells that can be isolated from a variety of tissues. MSCs that have been isolated from bone marrow and subsequently cultured can differentiate to a variety of cell types, most notably adipocytes, osteocytes and chondrocytes. MSCs also have immunomodulatory effects in vivo and in vitro. In 2006, the International Society for Cellular Therapy (ISCT) proposed a cell surface marker panel for the minimal identification of human MSCs derived from bone marrow. Under this recommendation MSCs should be positive for CD73, CD90, and CD105, but be negative for CD34, CD45, CD11b or CD14, CD19 or CD79α, and HLA-DR. MSCs are also known to express numerous cell surface markers such as CD44, CD29, CD200, CD166, CD146 and CD271. This lineage set includes the set of ISCT negative markers as a cocktail and also a corresponding isotype control cocktail.
Description of Set Components
Vial
Contents
Purpose
PE hMSC Negative Cocktail
CD34 PE (Clone:581)
Cocktail to identify potential contaminants
CD11b PE (Clone: ICRF44)
CD19 PE (Clone: HIB19)
CD45 PE (Clone: HI30)
HLA-DR PE (Clone: G46-6)
PE hMSC Isotype Control Negative Cocktail
mIgG1, κ PE (Clone: X40)
Corresponding isotype control for PE hMSC
mIgG2a, κ PE (Clone:G155-178)
Negative Cocktail

商品描述
Human multipotent mesenchymal stromal cells (MSCs), also referred to as mesenchymal stem cells, are a rare population of adult stem cells that can be isolated from a variety of tissues. MSCs that have been isolated from bone marrow and subsequently cultured can differentiate to a variety of cell types, most notably adipocytes, osteocytes and chondrocytes. MSCs also have immunomodulatory effects in vivo and in vitro. In 2006, the International Society for Cellular Therapy (ISCT) proposed a cell surface marker panel for the minimal identification of human MSCs derived from bone marrow. Under this recommendation MSCs should be positive for CD73, CD90, and CD105, but be negative for CD34, CD45, CD11b or CD14, CD19 or CD79α, and HLA-DR. MSCs are also known to express numerous cell surface markers such as CD44, CD29, CD200, CD166, CD146 and CD271. This lineage set includes the set of ISCT negative markers as a cocktail and also a corresponding isotype control cocktail.
Description of Set Components
Vial
Contents
Purpose
PE hMSC Negative Cocktail
CD34 PE (Clone:581)
Cocktail to identify potential contaminants
CD11b PE (Clone: ICRF44)
CD19 PE (Clone: HIB19)
CD45 PE (Clone: HI30)
HLA-DR PE (Clone: G46-6)
PE hMSC Isotype Control Negative Cocktail
mIgG1, κ PE (Clone: X40)
Corresponding isotype control for PE hMSC
mIgG2a, κ PE (Clone:G155-178)
Negative Cocktail

BD化合物表
- 描述数量/尺寸零件号EntrezGene ID
- PE hMSC Negative Cocktail50 Tests (1 ea)51-9007661N/A
- PE hMSC Isotype Control Negative Cocktail50 Tests (1 ea)51-9007662N/A
应用
实验应用
Flow cytometry (Tested During Development)

反应种属
Human (QC Testing)

文献
文献
研发参考(5)
1. Bühring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci. 2007; 1106:262-271. (Biology: Flow cytometry).
2. Dominici M, Le Blanc K, Mueller I, et. al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-317. (Biology: Flow cytometry).
3. Horwitz EM, Le Blanc K, Dominici M, et. al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005; 7(5):393-395. (Biology).
4. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-1301. (Biology: Flow cytometry).
5. Sánchez L, Gutierrez-Aranda I, Ligero G, et al. Enrichment of Human ESC-Derived Multipotent Mesenchymal Stem Cells with Immunosuppressive and Anti-Inflammatory Properties Capable to Protect Against Experimental Inflammatory Bowel Disease. Stem Cells. 2010; 29(2):251-262. (Biology: Cell differentiation).

参考图片
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。